{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:07:38Z","timestamp":1790906858701,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Fluoresc"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\nBased on their reaction with highly fluorescent carbon quantum dots (CQDts), a precise and reliable spectrofluorometric approach was developed for the determination of three calcium channel blockers. The studied drugs are: lercanidipine, nimodipine and nifedipine. (CQDts) were produced using a one-step hydrothermal method with ascorbic acid as the carbon source. The produced CQDts were capped by alcohol to create yellow emitters displaying a high fluorescence emission at 524\u00a0nm when excited at 325\u00a0nm. The fluorescence intensity of CQDts was noticeably quenched by each of the three calcium channel blockers. The relation between their concentrations and fluorescence quenching is linear over the concentration range of 0.5\u201320\u00a0\u00b5g\/mL for each of the three drugs. A full factorial design was used to optimize the effect of variable factors. Therefore, under optimum experimental design conditions, the detection limits for lercanidipine, nimodipine, and nifedipine were 0.11\u2009\u00b1\u20091.09, 0.10\u2009\u00b1\u20090.25 and 0.12\u2009\u00b1\u20090.71\u00a0\u00b5g\/mL, respectively. The LOQ was 0.33, 0.30, and 0.37\u00a0\u00b5g\/mL respectively. The quenching of fluorescent CQDts occurred through the inner filter effect (IFE) for nimodipine, while it was mixed with dynamic quenching for lercanidipine and nifedipine. The proposed method was effectively used to determine the cited drugs in their pharmaceutical products and had an acceptable level of precision. The selectivity of the CQDts system towards the studied drugs was examined indicating no interference from interfering species.<\/jats:p>","DOI":"10.1007\/s10895-022-03089-9","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T11:18:45Z","timestamp":1670498325000},"page":"671-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Design-assisted Spectrofluorometric Method Utilizing a One-pot Fluorescent Probe for the Quantitation of some Calcium Channel Blockers"],"prefix":"10.1007","volume":"33","author":[{"given":"Aya","family":"Roshdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa Abdel","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Hadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathallah","family":"Belal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Elmansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"issue":"1","key":"3089_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.ajkd.2020.04.017","volume":"77","author":"KS Fay","year":"2021","unstructured":"Fay KS, Cohen DL (2021) Resistant hypertension in people with CKD: a review. Am J Kidney Dis 77(1):110\u2013121","journal-title":"Am J Kidney Dis"},{"key":"3089_CR2","unstructured":"McDonagh MS, Eden KB, Peterson K (2005) Drug class review: Calcium channel blockers: Final report 20496186"},{"key":"3089_CR3","first-page":"1123","volume":"60","author":"KJ McClellan","year":"2000","unstructured":"McClellan KJ, Jarvis B (2000) Lercanidipine: A Review of its Use in Hypertension. Ingenta Connect 60:1123\u20131140","journal-title":"Ingenta Connect"},{"key":"3089_CR4","first-page":"1431","volume":"2","author":"AS Kumari","year":"2010","unstructured":"Kumari AS, Subhasish S, Kaushik DK, Annapurna MM (2010) Spectrophotometric determination of lercanidipine hydrochloride in pharmaceutical formulations. Int J PharmTech Res 2:1431\u20131436","journal-title":"Int J PharmTech Res"},{"key":"3089_CR5","unstructured":"Agrawal A, Mittal K, Thakkar AR (2010) Estimation of lercanidipine by first derivative UV spectroscopy. Asian J Pharm Res Health Care 2(3):263\u2013265"},{"issue":"2","key":"3089_CR6","first-page":"84","volume":"6","author":"N Jain","year":"2011","unstructured":"Jain N, Jain R, Thakur N, Jain S, Jain DK (2011) Simultaneous spectrophotometric estimation of lercanidipine hydrochloride and atenolol in the tablet dosage form. Eurasian J Anal Chem 6(2):84\u201390","journal-title":"Eurasian J Anal Chem"},{"issue":"4","key":"3089_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/22297928.2016.1209429","volume":"6","author":"O Abd Elaziz","year":"2016","unstructured":"Abd Elaziz O, Farouk M, Tawakkol SM, Hemdan A, Shehata MA (2016) Different approaches in determination of lercanidipine in presence of its degradation products by stability indicating univariate and multivariate calibrations. Anal Chem Lett 6(4):313\u2013325","journal-title":"Anal Chem Lett"},{"key":"3089_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1365\/s10337-004-0465-8","volume":"61","author":"S Mihaljica","year":"2005","unstructured":"Mihaljica S, Radulovic D, Trbojevic J (2005) Determination of lercanidipine hydrochloride and its impurities in tablets. Chromatographia 61:25\u201329","journal-title":"Chromatographia"},{"key":"3089_CR9","first-page":"38","volume":"1","author":"PS Bansode","year":"2014","unstructured":"Bansode PS, Ranawat MS, Kamble R, Chauhan CS (2014) Development and validation of lercanidipine hydrochloride and atenolol by using RP-HPLC and UV spectroscopy. Indian J Pharm Pharmacol 1:38\u201341","journal-title":"Indian J Pharm Pharmacol"},{"issue":"3","key":"3089_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/0250-474X.70490","volume":"72","author":"HO Kaila","year":"2010","unstructured":"Kaila HO, Ambasana MA, Thakkar RS, Saravaia HT, Shah AK (2010) A stability-indicating HPLC method for assay of lercanidipine hydrochloride in tablets and for determining content uniformity. Indian J Pharm Sci 72(3):381","journal-title":"Indian J Pharm Sci"},{"key":"3089_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0731-7085(02)00601-5","volume":"31.1","author":"A \u00c1lvarez-Lueje","year":"2003","unstructured":"\u00c1lvarez-Lueje A, Pujol S, Squella JA, N\u00fa\u00f1ez-Vergara LJ (2003) A selective HPLC method for determination of lercanidipine in tablets. J Pharm Biomed Anal 31.1:1\u20139","journal-title":"J Pharm Biomed Anal"},{"key":"3089_CR12","unstructured":"Pharmacopoeia B (2009)\u00a0The Majesty\u2019s stationery office. London, UK, 1, p 2011416. online version"},{"key":"3089_CR13","unstructured":"Lahoti S,\u00a0Toshniwal S (2012) Development and validation of UV spectrophotometric method of nimodipine in bulk and tablet formulation. Asian J Biomed Pharm Sci 2(7):8\u201310"},{"key":"3089_CR14","unstructured":"Revanasiddappa HD, Deepakumari HN, Mallegowda SM, Vinay KB (2011) Facile spectrophotometric determination of nimodipine and nitrazepam in pharmaceutical preparations. Analele Universitatii Bucuresti Chimie 20(2):189\u2013196"},{"issue":"1","key":"3089_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0378-5173(94)00399-P","volume":"119","author":"G Ragno","year":"1995","unstructured":"Ragno G, Veronico M, Vetuschi C (1995) Analysis of nimodipine and its photodegradation product by derivative spectrophotometry and gas chromatography. Int J Pharm 119(1):115\u2013119","journal-title":"Int J Pharm"},{"key":"3089_CR16","doi-asserted-by":"crossref","unstructured":"Deepakumari HN, Revanasiddappa HD (2013) A sensitive spectrophotometric estimation of nimodipine in tablets and injection using phloroglucinol. Int Scholarly Res Notices 2013:1\u20137","DOI":"10.1155\/2013\/980754"},{"key":"3089_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.saa.2015.05.026","volume":"149","author":"AM Mohamed","year":"2015","unstructured":"Mohamed AM, Omar MA, Hammad MA, Mohamed AA (2015) Spectrofluorimetric and micelle-enhanced spectrofluorimetric methods for determination of Felodipine and Nimodipine in pharmaceutical preparations and human plasma. Spectrochim Acta Part A Mol Biomol Spectrosc 149:934\u2013940","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"issue":"4","key":"3089_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1590\/S1984-82502010000400008","volume":"46","author":"DF Nascimento","year":"2010","unstructured":"Nascimento DF, Moraes MO, Bezerra FA, Pontes AV, Uchoa CR, Moraes RA, Leite IO, Santana GS, Santana AP, Pedrazzoli J\u00fanior J, Moraes ME (2010) Determination of nimodipine in plasma by HPLC-MS\/MS and pharmacokinetic application. Braz J Pharm Sci 46(4):665\u2013677","journal-title":"Braz J Pharm Sci"},{"issue":"6","key":"3089_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/chromsci\/bms174","volume":"51","author":"MK Riekes","year":"2013","unstructured":"Riekes MK, Rauber GS, Kuminek G, Tagliari MP, Cardoso SG, Stulzer HK (2013) Determination of nimodipine in the presence of its degradation products and overall kinetics through a stability-indicating LC method. J Chromatogr Sci 51(6):511\u2013516","journal-title":"J Chromatogr Sci"},{"issue":"2","key":"3089_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/chromsci\/48.2.81","volume":"48","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Zhai D, Chen X, Yu Q, He H, Sun Y, Gao Z, Wang L, Wang H, Han DE, Ji H (2010) Determination of nimodipine in human plasma by HPLC-ESI-MS and its application to a bioequivalence study. J Chromatogr Sci 48(2):81\u201385","journal-title":"J Chromatogr Sci"},{"issue":"2","key":"3089_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jchromb.2003.12.001","volume":"802","author":"F Qiu","year":"2004","unstructured":"Qiu F, Chen X, Li X, Zhong D (2004) Determination of nimodipine in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method. J Chromatogr B 802(2):291\u2013297","journal-title":"J Chromatogr B"},{"issue":"4","key":"3089_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.18388\/abp.2005_3407","volume":"52","author":"N Rahman","year":"2005","unstructured":"Rahman N, Azmi SN (2005) New spectrophotometric methods for the determination of nifedipine in pharmaceutical formulations. Acta Biochim Pol 52(4):915\u2013922","journal-title":"Acta Biochim Pol"},{"key":"3089_CR23","doi-asserted-by":"publisher","first-page":"S1603","DOI":"10.1016\/j.arabjc.2012.04.025","volume":"9","author":"P Tulasamma","year":"2016","unstructured":"Tulasamma P, Venkateswarlu P (2016) Spectrophotometric determination of nifedipine in pharmaceutical formulations, serum and urine samples via oxidative coupling reaction. Arab J Chem 9:S1603\u2013S1609","journal-title":"Arab J Chem"},{"issue":"103","key":"3089_CR24","first-page":"2","volume":"1","author":"MA Hamd","year":"2015","unstructured":"Hamd MA, Abdellatif AA, Derayea SM, Abdelmageed OH, Askal HF (2015) Spectrophotometric determination of Nifedipine and Nicardipine in their pharmaceutical preparations. Ind Chem 1(103):2","journal-title":"Ind Chem"},{"issue":"4","key":"3089_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0731-7085(01)00474-5","volume":"26","author":"D Castro","year":"2001","unstructured":"Castro D, Moreno MA, Lastres JL (2001) First-derivative spectrophotometric and LC determination of nifedipine in Brij\u00ae 96 based oil\/water\/oil multiple microemulsions on stability studies. J Pharm Biomed Anal 26(4):563\u2013572","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"3089_CR26","first-page":"635","volume":"52","author":"AB Tabrizi","year":"2007","unstructured":"Tabrizi AB (2007) A new spectrofluorimetric method for determination of nifedipine in pharmaceutical formulations. Chem Anal 52(4):635","journal-title":"Chem Anal"},{"issue":"2","key":"3089_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2478\/s11532-008-0011-x","volume":"6","author":"S Al-Ghannam","year":"2008","unstructured":"Al-Ghannam S, Al-Olyan A (2008) Spectrofluorometric determination of nicardipine, nifedipine and isradipine in pharmaceutical preparations and biological fluids. Open Chem 6(2):222\u2013228","journal-title":"Open Chem"},{"key":"3089_CR28","doi-asserted-by":"crossref","unstructured":"Logoyda L, Korobko D, Kovalenko S, Ivanusa I (2017) Development of the methodology of the chromatographic determination of nifedipine in medicines. Asian J Pharm Clin Res 10(3):149\u2013152","DOI":"10.22159\/ajpcr.2017.v10i3.15841"},{"key":"3089_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpba.2016.08.004","volume":"131","author":"A Grigoriev","year":"2016","unstructured":"Grigoriev A, Nikitina A, Yaroshenko I, Sidorova A (2016) Development of an HPLC\u2013MS\/MS method for the simultaneous determination of nifedipine and lidocaine in human plasma. J Pharm Biomed Anal 131:13\u201319","journal-title":"J Pharm Biomed Anal"},{"issue":"1-2","key":"3089_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jchromb.2006.03.048","volume":"839","author":"D Zendelovska","year":"2006","unstructured":"Zendelovska D, Simeska S, Sibinovska O, Kostova E, Milo\u0161evska K, Jakovski K, Jovanovska E, Kikerkov I, Troja\u010danec J, Zafirov D (2006) Development of an HPLC method for the determination of nifedipine in human plasma by solid-phase extraction. J Chromatogr B 839(1\u20132):85\u201388","journal-title":"J Chromatogr B"},{"issue":"1","key":"3089_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/bio.4158","volume":"37","author":"MA Abdel Hamid","year":"2022","unstructured":"Abdel Hamid MA, Mabrouk MM, Ahmed HM, Samy B, Batakoushy HA (2022) Carbon quantum dots as a sensitive fluorescent probe for quantitation of pregabalin; application to real samples and content uniformity test. Luminescence 37(1):170\u2013176","journal-title":"Luminescence"},{"key":"3089_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.msec.2014.01.038","volume":"38","author":"VN Mehta","year":"2014","unstructured":"Mehta VN, Jha S, Kailasa SK (2014) One-pot green synthesis of carbon dots by using Saccharum officinarum juice for fluorescent imaging of bacteria (Escherichia coli) and yeast (Saccharomyces cerevisiae) cells. Mater Sci Eng, C 38:20\u201327","journal-title":"Mater Sci Eng, C"},{"issue":"26","key":"3089_CR33","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1021\/ja2036749","volume":"133","author":"V Gupta","year":"2011","unstructured":"Gupta V, Chaudhary N, Srivastava R, Sharma GD, Bhardwaj R, Chand S (2011) Luminescent graphene quantum dots for organic photovoltaic devices. J Am Chem Soc 133(26):9960\u20139963","journal-title":"J Am Chem Soc"},{"issue":"37","key":"3089_CR34","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1002\/adma.201200650","volume":"24","author":"P Huang","year":"2012","unstructured":"Huang P, Lin J, Wang X, Wang Z, Zhang C, He M, Wang K, Chen F, Li Z, Shen G, Cui D (2012) Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater 24(37):5104\u20135110","journal-title":"Adv Mater"},{"issue":"10","key":"3089_CR35","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1039\/C9AY02696G","volume":"12","author":"MJ Molaei","year":"2020","unstructured":"Molaei MJ (2020) Principles, mechanisms, and application of carbon quantum dots in sensors: a review. Anal Methods 12(10):1266\u20131287","journal-title":"Anal Methods"},{"key":"3089_CR36","doi-asserted-by":"crossref","unstructured":"Ganorkar SB, Shirkhedkar AA (2017) Design of experiments in liquid chromatography (HPLC) analysis of pharmaceuticals: Analytics, applications, implications and future prospects. Rev Anal Chem 36(3):20160025","DOI":"10.1515\/revac-2016-0025"},{"key":"3089_CR37","doi-asserted-by":"crossref","unstructured":"Wang X, Feng Y, Dong P, Huang J (2019) A mini review on carbon quantum dots: preparation, properties, and electrocatalytic application. Front Chem 4(7):671","DOI":"10.3389\/fchem.2019.00671"},{"key":"3089_CR38","doi-asserted-by":"crossref","unstructured":"Smith BC (2011) Fundamentals of fourier transform infrared spectroscopy. CRC Press","DOI":"10.1201\/b10777"},{"key":"3089_CR39","doi-asserted-by":"publisher","first-page":"S313","DOI":"10.1016\/j.jscs.2012.12.001","volume":"20","author":"MV Krishna","year":"2016","unstructured":"Krishna MV, Dash RN, Reddy BJ, Venugopal P, Sandeep P, Madhavi G (2016) Quality by Design (QbD) approach to develop HPLC method for eberconazole nitrate: application oxidative and photolytic degradation kinetics. J Saudi Chem Soc 20:S313\u2013S322","journal-title":"J Saudi Chem Soc"},{"key":"3089_CR40","doi-asserted-by":"crossref","unstructured":"Fisher RA (1992) Statistical methods for research workers. Breakthroughs in Statistics. Springer, New York, pp 66\u201370","DOI":"10.1007\/978-1-4612-4380-9_6"},{"key":"3089_CR41","unstructured":"Guideline IHT (2005)\u00a0Validation of analytical procedures: text and methodology. Q2 (R1) 1(20):5"},{"key":"3089_CR42","unstructured":"Miller J, Miller JC (2018)\u00a0Statistics and chemometrics for analytical chemistry. Pearson Education 256"},{"key":"3089_CR43","doi-asserted-by":"crossref","unstructured":"Albrecht C (2008)\u00a0Joseph R. Lakowicz: Principles of fluorescence spectroscopy. 1223\u20131224","DOI":"10.1007\/s00216-007-1822-x"}],"container-title":["Journal of Fluorescence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-022-03089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10895-022-03089-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-022-03089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T14:14:54Z","timestamp":1677248094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10895-022-03089-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3089"],"URL":"https:\/\/doi.org\/10.1007\/s10895-022-03089-9","relation":{},"ISSN":["1053-0509","1573-4994"],"issn-type":[{"value":"1053-0509","type":"print"},{"value":"1573-4994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"assertion":[{"value":"30 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as the study does not include any use of animals and humans.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Declaration"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}}]}}